GlassScriptPhysician profile
Meghan Murray
NPI 1164919239
$5,967.98
in general payments reported to CMS, 2019-2025
25 companies · $1,549 in 2025
The $1,549 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,187 · 2022: $2,090 · 2023: $399 · 2024: $743 · 2025: $1,549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,359 · Travel and Lodging: $307 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,358.87 |
| Travel and Lodging | $307.23 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,942.69 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $1,271.13 | 2021-2025 | General - Therapies, Varithena Administration Pack, Enroute Transcarotid Stent |
| Abbvie INC. | $1,038.52 | 2021-2025 | |
| Penumbra, INC. | $247.86 | 2024-2025 | Indigo System |
| Inspiremd LTD | $188.96 | 2025 | Cguard Prime Carotid Stent System |
| Janssen Pharmaceuticals, INC | $171.12 | 2021 | |
| Medtronic, INC. | $168.01 | 2021-2022 | |
| Stryker Corporation | $141.91 | 2025 | Artix Mt, Sonopet Iq |
| Baxter Healthcare | $138.72 | 2022-2024 | Floseal, Coseal |
| Tactile Systems Technology INC | $103.18 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Seagen INC. | $85.46 | 2021-2023 | Padcev |
| Intuitive Surgical, INC. | $74.39 | 2022-2024 | |
| Integra Lifesciences Corporation | $60.32 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $47.74 | 2021 | |
| Bioventus LLC | $44.53 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $37.48 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Koya Medical, INC. | $33.54 | 2025 | Koya Medical, Dayspring |
| Siemens Medical Solutions USA, INC. | $28.35 | 2021 | |
| Mindray Ds USA, INC. | $25.70 | 2024 | Te7 Max, Te X |
| Shockwave Medical, INC | $25.00 | 2023 | |
| Lemaitre Vascular, INC. | $23.00 | 2024 | Trivex System |
| W. L. Gore & Associates, INC. | $22.75 | 2022 | |
| Ibsa Pharma INC. | $18.34 | 2025 | Tirosint, Licart, Flector |
| Nevro Corp. | $16.05 | 2023 | Senza |
| Nestle Healthcare Nutrition INC. | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.